News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
9,199 Results
Type
Article (336)
Press Release (8863)
Section
Business (2880)
Career Advice (2)
Deals (2347)
Drug Delivery (2)
Drug Development (224)
FDA (43)
Job Trends (189)
News (5815)
Policy (737)
Tag
Academia (8)
Alliances (489)
Alzheimer's disease (5)
Antibody-drug conjugate (ADC) (2)
Approvals (42)
Artificial intelligence (5)
Bankruptcy (58)
Best Places to Work (177)
Breast cancer (2)
Cancer (17)
Career advice (2)
CAR-T (4)
Cell therapy (9)
Clinical research (181)
Collaboration (11)
COVID-19 (7)
CRISPR (1)
C-suite (3)
Data (12)
Denatured (3)
Depression (1)
Diagnostics (55)
Digital health (1)
Diversity (3)
Earnings (455)
Events (791)
Executive appointments (14)
FDA (44)
Funding (22)
Gene editing (1)
Gene therapy (4)
GLP-1 (4)
Government (16)
Healthcare (232)
Infectious disease (8)
Inflammatory bowel disease (2)
Intellectual property (2)
IPO (450)
Job creations (20)
Job search strategy (2)
Legal (625)
Lung cancer (7)
Lymphoma (2)
Manufacturing (5)
Medical device (177)
Medtech (177)
Mergers & acquisitions (1970)
Metabolic disorders (2)
Multiple sclerosis (1)
Neuroscience (9)
NextGen: Class of 2025 (101)
Non-profit (35)
Northern California (46)
Obesity (2)
Opinion (1)
Pain (1)
Patents (2)
Patient recruitment (3)
People (1781)
Phase I (60)
Phase II (83)
Phase III (50)
Pipeline (13)
Podcasts (3)
Postmarket research (5)
Preclinical (33)
Radiopharmaceuticals (9)
Rare diseases (1)
Real estate (20)
Regulatory (113)
Research institute (18)
Schizophrenia (1)
Series A (7)
Southern California (31)
Startups (98)
Supply chain (2)
United States (268)
Vaccines (5)
Venture capitalists (2)
Women's health (2)
Date
Last 7 days (1)
Last 30 days (42)
Last 365 days (484)
2025 (121)
2024 (490)
2023 (561)
2022 (634)
2021 (889)
2020 (736)
2019 (954)
2018 (569)
2017 (449)
2016 (374)
2015 (466)
2014 (341)
2013 (361)
2012 (317)
2011 (355)
2010 (285)
Location
Alabama (3)
Arizona (1)
Arkansas (1)
Asia (408)
Australia (27)
California (86)
Canada (48)
China (6)
Colorado (3)
Connecticut (3)
Europe (1571)
Florida (10)
Georgia (1)
Idaho (2)
Illinois (8)
India (1)
Indiana (8)
Japan (6)
Maryland (14)
Massachusetts (62)
Michigan (2)
Minnesota (2)
New Hampshire (2)
New Jersey (27)
New York (19)
North Carolina (10)
Northern California (46)
Ohio (3)
Pennsylvania (16)
Southern California (31)
Tennessee (7)
Texas (7)
Utah (1)
Virginia (1)
Washington D.C. (1)
Washington State (3)
9,199 Results for "abingworth llp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ME Therapeutics Announces It Has Engaged Lucosky Brookman LLP to Explore a Listing on the NASDAQ or NYSE
March 3, 2025
·
4 min read
Press Releases
Sunflower Therapeutics Engages PharmNXT Biotech LLP as Distributor for the Daisy Petal™ Perfusion Bioreactor System
February 26, 2025
·
3 min read
Press Releases
Bleichmar Fonti & Auld LLP Announces a Proposed Settlement in the In re Talis Biomedical Corporation Securities Litigation
December 23, 2024
·
4 min read
Business
Hoth Therapeutics Retains Venable LLP to Expand Its Patent Portfolio
Hoth Therapeutics, Inc. today announced that it will continue its work with Venable, LLP to develop and protect its intellectual property.
February 29, 2024
·
4 min read
BioMidwest
Foldax, Inc. Signs Manufacturing Agreement with Dolphin Life Science India LLP to Expedite Upcoming Commercial Availability
Foldax® Inc., a pioneer in the development of innovative, polymer heart valves, announced a manufacturing agreement with Dolphin Life Science India LLP to enable in-country manufacturing of the TRIA™ polymer mitral surgical heart valve outside of the U.S. for the first time.
February 27, 2024
·
2 min read
Press Releases
I-Mab Appoints U.S. Auditor, PricewaterhouseCoopers LLP (PwC)
August 7, 2024
·
4 min read
Genetown
Clinical Collaboration Agreement between Teva and Launch Therapeutics to Accelerate Development of Dual-Action Asthma Rescue Inhaler (ICS-SABA/TEV-’248) Respiratory Program; Teva and Abingworth Enter Strategic Development Funding Agreement
Teva Pharmaceutical Industries Ltd. and Launch Therapeutics, Inc., announced a clinical collaboration agreement to further accelerate the clinical research program of Teva’s ICS-SABA.
April 1, 2024
·
9 min read
Press Releases
Quantum BioPharma Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing
Christian Attar Law Firm and Freedman Normand Friedland LLP, in conjunction with forensic investigators, have uncovered evidence of a potential multi-year market manipulation scheme that has caused substantial damages to the Company and its shareholders
October 21, 2024
·
10 min read
Biotech Bay
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
Soleno Therapeutics, Inc. announced it has entered into a Securities Purchase Agreement with Nantahala Capital Management, LLC, Abingworth LLP and Vivo Capital, LLC for up to $60 million.
December 19, 2022
·
6 min read
Business
Exicure Appoints Dr. Bali Muralidhar of Abingworth LLP and Bosun Hau of Tybourne Capital Management to its Board of Directors
Dr. Bali Muralidhar, a partner at Abingworth LLP, and Mr. Bosun Hau, a managing director and co-head of private equity at Tybourne Capital Management, to its Board of Directors.
August 7, 2019
·
4 min read
1 of 920
Next
